Doganay M - Search Results

1

Human Anthrax: Update of the Diagnosis and Treatment.

Doganay M, Dinc G, Kutmanova A, Baillie L. Doganay M, et al. Diagnostics (Basel). 2023 Mar 10;13(6):1056. doi: 10.3390/diagnostics13061056. Diagnostics (Basel). 2023. PMID: 36980364 Free PMC article. Review.

2

An Overwiev of ORF Virus Infection in Humans and Animals.

Demiraslan H, Dinc G, Doganay M. Demiraslan H, et al. Among authors: doganay m. Recent Pat Antiinfect Drug Discov. 2017;12(1):21-30. doi: 10.2174/1574891X12666170602080301. Recent Pat Antiinfect Drug Discov. 2017. PMID: 28571550 Review.

3

Human anthrax in Kyrgyz Republic: Epidemiology and clinical features.

Kutmanova A, Doganay M, Zholdoshev S. Kutmanova A, et al. Among authors: doganay m. J Infect Public Health. 2020 Aug;13(8):1161-1165. doi: 10.1016/j.jiph.2020.02.043. Epub 2020 Apr 8. J Infect Public Health. 2020. PMID: 32276875 Free article.

4

Natural cutaneous anthrax infection, but not vaccination, induces a CD4(+) T cell response involving diverse cytokines.

Ingram RJ, Ascough S, Reynolds CJ, Metan G, Doganay M, Baillie L, Williamson DE, Robinson JH, Maillere B, Boyton RJ, Altmann DM. Ingram RJ, et al. Among authors: doganay m. Cell Biosci. 2015 Apr 26;5:20. doi: 10.1186/s13578-015-0011-4. eCollection 2015. Cell Biosci. 2015. PMID: 26075052 Free PMC article.

5

Investigation of double-carbapenem efficiency in experimental sepsis of colistin-resistant Klebsiella pneumoniae.

Kosar I, Dinc G, Eren E, Aykemat Y, Kilic M, Kilic H, Doganay M. Kosar I, et al. Among authors: doganay m. North Clin Istanb. 2021 Mar 10;8(2):113-118. doi: 10.14744/nci.2020.14238. eCollection 2021. North Clin Istanb. 2021. PMID: 33851073 Free PMC article.

6

[No title available]

[No authors listed] [No authors listed] PMID: 36161642

7

The efficacy of mesenchymal stem cell therapy in experimental sepsis induced by carbapenem-resistant K. pneumoniae in neutropenic mice model.

Dinc G, Eren E, Kontas O, Doganay M. Dinc G, et al. Among authors: doganay m. Eur J Clin Microbiol Infect Dis. 2020 Sep;39(9):1739-1744. doi: 10.1007/s10096-020-03910-y. Epub 2020 Apr 30. Eur J Clin Microbiol Infect Dis. 2020. PMID: 32356028

8

Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis.

Dinc G, Demiraslan H, Elmali F, Ahmed SS, Metan G, Alp E, Doganay M. Dinc G, et al. Among authors: doganay m. Chemotherapy. 2013;59(5):325-9. doi: 10.1159/000356755. Epub 2014 Feb 13. Chemotherapy. 2013. PMID: 24525528

9

Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii.

Dinc G, Demiraslan H, Elmali F, Ahmed SS, Alp E, Doganay M. Dinc G, et al. Among authors: doganay m. New Microbiol. 2015 Jan;38(1):67-73. Epub 2015 Jan 1. New Microbiol. 2015. PMID: 25742149 Free article.

10

The investigation of adrenal involvement in carbapenem resistant Acinetobacter baumannii sepsis: experimental mouse model.

Eryılmaz-Eren E, Dinç G, Kontaş O, Alp E, Doğanay M. Eryılmaz-Eren E, et al. Among authors: doganay m. Turk J Med Sci. 2021 Dec 13;51(6):3108-3114. doi: 10.3906/sag-2001-163. Turk J Med Sci. 2021. PMID: 34493028 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

228 results

Search Page